<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(17)</volume><submitter>Jin W</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>To evaluate the diagnostic accuracy of metagenomic next-generation sequencing (mNGS) for active tuberculosis (TB).&lt;h4>Methods&lt;/h4>We retrospectively collected 820 samples at Zhongshan Hospital, Fudan University in Shanghai, China, between 1 April 2017 and 31 March 2018. They were classified into TB cases (125, 15.2%) and NOT TB cases (695, 84.8%) according to the clinical diagnosis. Specimens were evaluated by a regular clinical microbiological assay and mNGS performed in parallel.&lt;h4>Results&lt;/h4>Sixty-one confirmed TB cases and 64 clinical TB cases were included. The overall sensitivity of mNGS was 49.6% [95% confidence interval (95% CI), 40.6-58.6%], and the specificity was 98.3% (95% CI, 96.9-99.1%), with peak sensitivities of 88.9% (95% CI, 50.7-99.4%) for lung tissu</pubmed_abstract><journal>Annals of translational medicine</journal><pagination>1065</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7575944</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Diagnostic accuracy of metagenomic next-generation sequencing for active tuberculosis in clinical practice at a tertiary general hospital.</pubmed_title><pmcid>PMC7575944</pmcid><pubmed_authors>Miao Q</pubmed_authors><pubmed_authors>Jin W</pubmed_authors><pubmed_authors>Ma Y</pubmed_authors><pubmed_authors>Bao R</pubmed_authors><pubmed_authors>Hu B</pubmed_authors><pubmed_authors>Wu H</pubmed_authors><pubmed_authors>Wang M</pubmed_authors><pubmed_authors>Pan J</pubmed_authors><pubmed_authors>Yao Y</pubmed_authors><pubmed_authors>Huang Y</pubmed_authors><pubmed_authors>Wang Q</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Li B</pubmed_authors><pubmed_authors>Gao X</pubmed_authors><pubmed_authors>Su Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Diagnostic accuracy of metagenomic next-generation sequencing for active tuberculosis in clinical practice at a tertiary general hospital.</name><description>&lt;h4>Background&lt;/h4>To evaluate the diagnostic accuracy of metagenomic next-generation sequencing (mNGS) for active tuberculosis (TB).&lt;h4>Methods&lt;/h4>We retrospectively collected 820 samples at Zhongshan Hospital, Fudan University in Shanghai, China, between 1 April 2017 and 31 March 2018. They were classified into TB cases (125, 15.2%) and NOT TB cases (695, 84.8%) according to the clinical diagnosis. Specimens were evaluated by a regular clinical microbiological assay and mNGS performed in parallel.&lt;h4>Results&lt;/h4>Sixty-one confirmed TB cases and 64 clinical TB cases were included. The overall sensitivity of mNGS was 49.6% [95% confidence interval (95% CI), 40.6-58.6%], and the specificity was 98.3% (95% CI, 96.9-99.1%), with peak sensitivities of 88.9% (95% CI, 50.7-99.4%) for lung tissu</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Sep</publication><modification>2025-04-19T23:38:59.38Z</modification><creation>2025-04-19T23:38:59.38Z</creation></dates><accession>S-EPMC7575944</accession><cross_references><pubmed>33145284</pubmed><doi>10.21037/atm-20-2274</doi></cross_references></HashMap>